semaglutide nash phase 3 shows liver benefits in MASH trial Semaglutide 2·4 mg once weekly

What happens during the procedure

Clinical trial data shows that burping rates vary by drug and dose: Ozempic injection (semaglutide): Burping reported in 3% of patients at the 0.5 mg dose and 1% of patients at the 1 mg dose Wegovy injection (semaglutide): Burping reported in 7% of adults at the 2.4 mg dose Mounjaro and Zepbound (tirzepatide): Burping reported in 25% of patients across doses (Source: Drugs.com) These numbers likely underestimate real-world prevalence, as sulfur burps are often underreported in clinical trials or described under broader terms like belching or eructation. Some patients avoid mentioning it to their doctors out of embarrassment, as well

Ask our team about hormone evaluation during your consultation

These events are well recognised with incretin-based therapies such as GLP-1 receptor agonists, and retatrutide has shown a similar pattern in the early studies

At this time, Kentuckys Medicaid program only covers GLP-1 drugs for Type 2 diabetes.

The best alternative depends on the reason for treatment